Jamjoom Pharma Receives Approval from the Food and Drug Authority for Sterile Products Factory in Jeddah

Jamjoom Pharmaceuticals Factory Company announced on Sunday the issuance of the Saudi Food and Drug Authority’s (SFDA) approval to register the new Sterile Facility (ophthalmic products) in Jeddah.

The Company said on Tadawul that the state-of-the-art facility is built on an area of 7,500 sqm in phase 5 of the Jeddah Industrial District and costs approximately SAR 200 million in construction. The facility specialises in producing sterile products (ophthalmic products), and its annual production capacity will reach 25 million units at full operations.

Commercial production at this facility will commence once the relevant product approvals have been obtained from the SFDA.